Romano Brothers And Company Novo Nordisk A S Transaction History
Romano Brothers And Company
- $757 Million
- Q1 2025
A detailed history of Romano Brothers And Company transactions in Novo Nordisk A S stock. As of the latest transaction made, Romano Brothers And Company holds 6,373 shares of NVO stock, worth $370,143. This represents 0.06% of its overall portfolio holdings.
Number of Shares
6,373
Previous 6,328
0.71%
Holding current value
$370,143
Previous $544,000
18.75%
% of portfolio
0.06%
Previous 0.07%
Shares
10 transactions
Others Institutions Holding NVO
# of Institutions
1,870Shares Held
336MCall Options Held
11.9MPut Options Held
10.6M-
Jennison Associates LLC19.9MShares$1.16 Billion1.06% of portfolio
-
Bank Of America Corp Charlotte, NC15.5MShares$900 Million0.11% of portfolio
-
Gqg Partners LLC Ft. Lauderdale, FL13MShares$755 Million1.67% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.6MShares$734 Million0.44% of portfolio
-
Morgan Stanley New York, NY12.2MShares$709 Million0.08% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $131B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...